EditorialKommentar
Is Equity Being Traded for Access to Heart Transplant?
JAMA · 2024
DOI: 10.1001/jama.2024.0812 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, 2024. Verfasst von Paul A Heidenreich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University School of Medicine, Stanford, California. Hauptthemen laut MEDLINE: Health Equity, Healthcare Disparities, Heart Failure, Heart Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Health EquityHealthcare DisparitiesHeart FailureHeart TransplantationTissue and Organ ProcurementFemaleHumansMaleAsianBlack or African AmericanEthnicityHealth Services AccessibilityHispanic or LatinoRace FactorsSex FactorsSocial ClassUnited StatesWaiting ListsWhite
Autor:innen und Institutionen
- Department of Medicine, Stanford University School of Medicine, Stanford, California.
- VA Palo Alto Health Care System, Palo Alto, California.
Zitieren
APA
Heidenreich, P. A., Lewis, E. F., & Khush, K. K. (2024). Is Equity Being Traded for Access to Heart Transplant?. JAMA. https://doi.org/10.1001/jama.2024.0812
Vancouver
Heidenreich PA, Lewis EF, Khush KK. Is Equity Being Traded for Access to Heart Transplant?. JAMA. 2024. doi:10.1001/jama.2024.0812
BibTeX
@article{Heidenreich2024,
author = {Heidenreich, Paul A and Lewis, Eldrin F and Khush, Kiran K},
title = {Is Equity Being Traded for Access to Heart Transplant?},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.0812}
}
EUVIMED